...
机译:以“新时代”标志物Brachyury复查脊索瘤:对51例病例的有效性研究分析
Nirmala A. Jambhekar, MD, Bharat Rekhi, MD, DNB, MIAC, Kiran Thorat, MD, Rajesh Dikshit, PhD, Manish Agrawal, MS, DNB, Ajay Puri, MSAccepted for publication October 22, 2009.From the Departments of Pathology (Drs Jambhekar, Rekhi, and Thorat), Epidemiology and Biostatistics (Dr Dikshit), and Orthopedic Surgical Oncology (Drs Agrawal and Puri), Tata Memorial Hospital, Parel, Mumbai, India.The authors have no relevant financial interest in the products or companies described in this article.Presented in part at the annual meeting of the United States and Canadian Academy of Pathologists, Boston, Massachusetts, March 7- 13, 2009.Reprints: Bharat Rekhi, MD, DNB, MIAC, Department of Pathology, 8th Floor Annexe Building, Tata Memorial Hospital, Dr E. B. Road, Parel, Mumbai 400 012, India (e-mail: rekhi.bharat@gmail.com).,;
机译:伴有“新时代”标志的腕毛瘤重现脊索瘤:对51例病例的验证研究分析。
机译:Brachyury,SOX-9和Podoplanin,颅底脊索瘤与软骨肉瘤鉴别的新标志物:基于组织芯片的比较分析
机译:使用SSR标记分析遗传多样性和群体结构,并验证涉及钠转运蛋白酸钠的乳化剂(帽)标记物的乳化溶剂; 5在盐水耐稻(Oryza Sativa L.)Landraces中
机译:基于聚类验证指标的疲劳损伤聚类分析技术验证研究
机译:LC-MS / MS分析动物废物标记物的验证和现场测试。
机译:BrachyurySOX-9和Podoplanin颅底脊索瘤与软骨肉瘤鉴别的新标记:基于组织芯片的比较分析
机译:重新审视脊索瘤与Brachyury,一个“新时代”标记:分析51例验证研究